HPD has been observed in patients with melanoma, colorectal cancer, non-small cell lung carcinoma, head and neck cancer, ovarian cancer and lymphoma upon treatment with anti-PD-1/PD-L1 mAb therapy [100]. This evidence concerns the gene CD274 and head and neck cancer.